<SEC-DOCUMENT>0001575872-25-000589.txt : 20250922
<SEC-HEADER>0001575872-25-000589.hdr.sgml : 20250922
<ACCEPTANCE-DATETIME>20250922115250
ACCESSION NUMBER:		0001575872-25-000589
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20250922
FILED AS OF DATE:		20250922
DATE AS OF CHANGE:		20250922

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DR REDDYS LABORATORIES LTD
		CENTRAL INDEX KEY:			0001135951
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			K7
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15182
		FILM NUMBER:		251329202

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		8-2-337, ROAD NO.3 BANJARA HILLS
		CITY:			HYDERABAD
		PROVINCE COUNTRY:   	K7
		ZIP:			500-034
		BUSINESS PHONE:		91 40 49002900

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		8-2-337, ROAD NO.3 BANJARA HILLS
		CITY:			HYDERABAD
		PROVINCE COUNTRY:   	K7
		ZIP:			500-034
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>rdy0807_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<html><head><meta charset="UTF-8"></head><body><div><div align="left" class="Ruletopscotch" style="margin-top: 12pt; margin-bottom: 3pt; margin-left: 0in;"><div style="border-top: 2pt solid rgb(0, 0, 0); border-bottom: 1pt solid rgb(0, 0, 0); width: 100%; font-size: 2pt;">&#160;</div></div><p class="MsoSubtitle nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 12pt;font-weight: bold;font-family: &quot;Times New Roman&quot;, Times, serif;margin: 0px 0px 0px 0in;text-align: center;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;"><font style="text-decoration: none; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0);">&#160;</font></font></p><p class="MsoSubtitle" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 12pt;font-weight: bold;font-family: &quot;Times New Roman&quot;, Times, serif;margin: 0px 0px 0px 0in;text-align: center;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 14pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">SECURITIES AND EXCHANGE COMMISSION</font></p><p align="center" class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;text-align: center;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;background: none;text-indent: 0px"><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></b></p><p align="center" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;text-align: center;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;background: none;text-indent: 0px"><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Washington, D.C. 20549</font></b></p><p align="center" class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 11pt;margin: 0px 0px 0px 0in;text-align: center;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p align="center" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;text-align: center;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 18pt;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Form 6-K</font></p><p align="center" class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 11pt;margin: 0px 0px 0px 0in;text-align: center;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p align="center" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;text-align: center;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 12pt;background: none;text-indent: 0px"><b><font lang="EN-US" style="font-size: 12pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16</font></b></p><p align="center" class="xl39" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 9pt;margin: 0px 0px 0px 0in;text-align: center;font-weight: bold;font-family: &quot;Times New Roman&quot;, Times, serif;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 12pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">UNDER THE SECURITIES EXCHANGE ACT OF 1934</font></p><p align="center" class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;text-align: center;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p align="center" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;text-align: center;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 12pt;background: none;text-indent: 0px"><b><font lang="EN-US" style="font-size: 12pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">September, 2025</font></b></p><p align="center" class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;text-align: center;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p align="center" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;text-align: center;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 12pt;background: none;text-indent: 0px"><b><font lang="EN-US" style="font-size: 12pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Commission File Number 1-15182</font></b></p><p align="center" class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;text-align: center;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p class="SubTitle" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 10pt;margin: 0px 0px 0px 0in;font-weight: bold;font-family: &quot;Times New Roman&quot;, Times, serif;text-align: center;text-transform: uppercase;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 24pt; text-transform: none; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">DR. REDDY&#8217;S LABORATORIES LIMITED</font></p><p align="center" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;text-align: center;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">(Translation of registrant&#8217;s name into English)</font></p><p align="center" class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;text-align: center;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p align="center" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;text-align: center;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;background: none;text-indent: 0px"><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">8-2-337, Road No. 3, Banjara Hills</font></b></p><p align="center" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;text-align: center;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;background: none;text-indent: 0px"><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Hyderabad, Telangana 500 034, India</font></b></p><p class="SubTitle" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 10pt;margin: 0px 0px 0px 0in;font-weight: bold;font-family: &quot;Times New Roman&quot;, Times, serif;text-align: center;text-transform: uppercase;background: none;text-indent: 0px">+91-40-49002900<font class="" lang="EN-US" style="text-transform: none; font-family: &quot;Times New Roman&quot;, Times, serif; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;"></font></p><p align="center" class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;text-align: center;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p align="center" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;text-align: center;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">(Address of principal executive office)</font></p><p align="center" class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;text-align: center;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p class="MsoBodyText2" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 12pt;margin: 0px 0px 0px 0in;text-align: justify;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;color: black;background: none;text-indent: 0px"><font lang="EN-GB" style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; background: none; letter-spacing: 0px; top: 0px;">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</font></p><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p align="center" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;text-align: center;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Form 20-F&#160; </font><font lang="EN-US" style="font-size: 10pt; font-family: Wingdings; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">x</font><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Form 40-F&#160;&#160; </font><font lang="EN-US" style="font-size: 10pt; font-family: Wingdings; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#168;</font><font class="" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;"></font></p><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p class="MsoBodyText2" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 12pt;margin: 0px 0px 0px 0in;text-align: justify;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;color: black;background: none;text-indent: 0px"><font lang="EN-GB" style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; background: none; letter-spacing: 0px; top: 0px;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):&#160; ______</font></p><p class="MsoBodyText2 nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 12pt;margin: 0px 0px 0px 0in;text-align: justify;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;color: black;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-GB" style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; letter-spacing: 0px; top: 0px;">&#160;</font></p><p class="MsoBodyText2" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 12pt;margin: 0px 0px 0px 0in;text-align: justify;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;color: black;background: none;text-indent: 0px"><b><font lang="EN-GB" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Note:</font></b><font lang="EN-GB" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160; Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.</font></p><p class="MsoBodyText2 nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 12pt;margin: 0px 0px 0px 0in;text-align: justify;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;color: black;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-GB" style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; letter-spacing: 0px; top: 0px;">&#160;</font></p><p class="MsoBodyText2" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 12pt;margin: 0px 0px 0px 0in;text-align: justify;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;color: black;background: none;text-indent: 0px"><font lang="EN-GB" style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; background: none; letter-spacing: 0px; top: 0px;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):&#160; ______</font></p><p class="MsoBodyText2 nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 12pt;margin: 0px 0px 0px 0in;text-align: justify;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;color: black;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-GB" style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; letter-spacing: 0px; top: 0px;">&#160;</font></p><p class="MsoBodyText2" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 12pt;margin: 0px 0px 0px 0in;text-align: justify;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;color: black;background: none;text-indent: 0px"><b><font lang="EN-GB" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Note:&#160; </font></b><font lang="EN-GB" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant&#8217;s &#8220;home country&#8221;), or under the rules of the home country exchange on which the registrant&#8217;s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant&#8217;s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.</font></p><p class="MsoBodyText2 nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 12pt;margin: 0px 0px 0px 0in;text-align: justify;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;color: black;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-GB" style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; letter-spacing: 0px; top: 0px;">&#160;</font></p><p class="MsoBodyText2" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 12pt;margin: 0px 0px 0px 0in;text-align: justify;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;color: black;background: none;text-indent: 0px"><font lang="EN-GB" style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; background: none; letter-spacing: 0px; top: 0px;">Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.</font></p><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p align="center" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;text-align: center;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Yes&#160; </font><font lang="EN-US" style="font-size: 10pt; font-family: Wingdings; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#168;</font><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; No&#160;&#160; </font><font lang="EN-US" style="font-size: 10pt; font-family: Wingdings; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">x</font><font class="" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;"></font></p><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">If &#8220;Yes&#8221; is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;background: none;text-indent: 0px"><font class="" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;"></font><br></p><div align="left" class="Rulebottomscotch" style="margin-top: 3pt; margin-bottom: 12pt; margin-left: 0in;"><div style="border-top: 1pt solid rgb(0, 0, 0); border-bottom: 2pt solid rgb(0, 0, 0); width: 100%; font-size: 2pt;">&#160;</div></div><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;background: none;text-indent: 0px"><font class="whitespaceprewrap " lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;"></font></p><div style="border-bottom:1pt solid #000000; break-after:page;text-indent: 0px;" title="Page Break" class="cke_pagebreak"></div><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 11pt;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;background: none;text-indent: 0px"><b><font style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">EXHIBITS </font></b><font class="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;"></font></p><p class="nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;background: none;text-indent: 0px"><font class="whitespaceprewrap" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><table cellpadding="0" cellspacing="0" class="Table" style="text-align:start; width: 100%; border-collapse: collapse; border-left-style: unset; border-right-style: unset; border-left-width: 0px; border-right-width: 0px; text-indent: 0px; border-spacing: 0px;" width="100%"><tr><td style="width: 10%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif; border-bottom: 1px solid black;" valign="top" width="10%"><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt"><b><font style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Exhibit </font></b></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 11pt;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif"><b><font style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Number</font></b><font class="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;"></font></p></td><td style="width: 1%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif;" valign="top" width="1%"><p class="nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt"><font class="whitespaceprewrap" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;&#160;</font></p></td><td style="width: 89%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif; border-bottom: 1px solid black;" valign="bottom" width="89%"><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 11pt;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif"><b><font style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Description of Exhibits</font></b><font class="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;"></font></p></td></tr><tr><td style="width: 10%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif;" valign="top" width="10%"><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt"><font class="whitespaceprewrap" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p></td><td style="width: 1%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif;" valign="top" width="1%"><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt"><font class="whitespaceprewrap" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p></td><td style="width: 89%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif;" valign="top" width="89%"><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt"><font class="whitespaceprewrap" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p></td></tr><tr><td style="width: 10%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif; background-color: rgb(204, 238, 255);" valign="top" width="10%"><p class="Default" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 12pt;font-family: &quot;Times New Roman&quot;, Times, serif;margin: 0px 0px 0px 0in;color: black;line-height: normal"><a class="" href="rdy0807_ex99-1.htm" manuallink="true" style="-sec-extract:exhibit"><font style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;">99.1</font><font class="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;"></font></a></p></td><td style="width: 1%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif; background-color: rgb(204, 238, 255);" valign="top" width="1%"><p class="Default nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 12pt;font-family: &quot;Times New Roman&quot;, Times, serif;margin: 0px 0px 0px 0in;color: black;line-height: normal"><br></p></td><td style="width: 89%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif; background-color: rgb(204, 238, 255);" valign="top" width="89%"><p class="Default" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 12pt;font-family: &quot;Times New Roman&quot;, Times, serif;margin: 0px 0px 0px 0in;color: black;line-height: normal"><a class="" href="rdy0807_ex99-1.htm" manuallink="true" style="-sec-extract:exhibit"><font style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;">Intimation dated September 22, 2025 </font></a></p></td></tr></table><div class="emptyHTML" style="clear:both;max-height:0pt;;text-indent: 0px;"></div><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;background: none;text-indent: 0px"><font class="whitespaceprewrap" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><table style="width:100%;border-collapse: collapse;"><tr><td></td><td style="font-family: Times New Roman, Times, serif;font-weight:normal;font-style:normal;font-size:10pt;text-align:center;vertical-align:Top;width:34%;padding: 0pt;">2</td><td></td></tr></table><div style="border-bottom:1pt solid #000000; break-after:page;text-indent: 0px;" title="Page Break" class="cke_pagebreak"></div><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;background: none;text-indent: 0px"><font class="whitespaceprewrap" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 11pt;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;background: none;text-indent: 0px"><b><font style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">SIGNATURES </font></b><font class="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;"></font></p><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;background: none;text-indent: 0px"><font class="whitespaceprewrap" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;text-align: justify;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;background: none;text-indent: 0px"><font style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. </font></p><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;background: none;text-indent: 0px"><font class="whitespaceprewrap" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;background: none;text-indent: 0px"><font class="whitespaceprewrap" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><table cellpadding="0" cellspacing="0" class="Table" style="text-align:start; width: 100%; border-collapse: collapse; border-left-style: unset; border-right-style: unset; border-left-width: 0px; border-right-width: 0px; text-indent: 0px; border-spacing: 0px;" width="100%"><tr><td style="padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif;" valign="top" width=""><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt"><font class="whitespaceprewrap" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p></td><td colspan="2" style="padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif;" valign="top" width=""><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt"><font style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">DR. REDDY&#8217;S LABORATORIES LIMITED</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt"><font style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">(Registrant)</font></p></td></tr><tr><td style="padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif;" valign="top" width=""><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt"><font class="whitespaceprewrap" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p></td><td colspan="2" style="padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif;" valign="top" width=""><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt"><font class="whitespaceprewrap" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p></td></tr><tr><td style="width: 50%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif;" valign="top" width="50%"><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt"><font style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Date: September 22, 2025 </font></p></td><td style="width: 4%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif;" valign="top" width="4%"><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt"><font style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">By:</font></p></td><td style="width: 46%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif; border-bottom: 0.75pt solid black;" valign="top" width="46%"><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt"><font style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">/s/ K Randhir Singh</font></p></td></tr><tr><td style="width: 50%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif;" valign="top" width="50%"><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt"><font class="whitespaceprewrap" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p></td><td style="width: 4%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif;" valign="top" width="4%"><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt"><font class="whitespaceprewrap" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p></td><td style="width: 46%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif;" valign="top" width="46%"><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt"><font style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Name: K Randhir Singh</font></p></td></tr><tr><td style="width: 50%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif;" valign="top" width="50%"><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt"><font class="whitespaceprewrap" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p></td><td style="width: 4%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif;" valign="top" width="4%"><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt"><font class="whitespaceprewrap" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p></td><td style="width: 46%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif;" valign="top" width="46%"><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt"><font style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Title: &#160;&#160;Company Secretary </font></p></td></tr></table><div class="emptyHTML" style="clear:both;max-height:0pt;;text-indent: 0px;"></div><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin: 0px 0px 0px 0in;line-height: normal;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><table style="width:100%;border-collapse: collapse;"><tr><td></td><td style="font-family: Times New Roman, Times, serif;font-weight:normal;font-style:normal;font-size:10pt;text-align:center;vertical-align:Top;width:34%;padding: 0pt;">3</td><td></td></tr></table><div style="border-bottom:1pt solid #000000; break-after:page;text-indent: 0px;" title="Page Break" class="cke_pagebreak"></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>rdy0807_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head><meta charset="UTF-8"></head><body><div><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p align="right" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: right;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;background: none;text-indent: 0px"><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Exhibit 99.1</font></b></p><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; color: rgb(0, 0, 0); white-space: pre-wrap; background: none; letter-spacing: 0px; top: 0px;">&#160;</font></p><table cellpadding="0" cellspacing="0" class="Table" style="text-align:start; width: 100%; border-collapse: collapse; border-left-style: unset; border-right-style: unset; border-left-width: 0px; border-right-width: 0px; text-indent: 0px; border-spacing: 0px;" width="100%"><tr><td style="width: 50%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif;" valign="top" width="50%"><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;line-height: normal"><img name="rdy0807_ex99-1img01.jpg" src="rdy0807_ex99-1img01.jpg" style="width: 178px; height: 39px;"><br></p></td><td style="width: 50%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif;" valign="top" width="50%"><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;margin-right: 0px;line-height: normal"><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Dr. Reddy's Laboratories Ltd</font></b><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">.</font></b></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;line-height: normal"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">8-2-337, Road No. 3, Banjara Hills</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;line-height: normal"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Hyderabad &#8211; 500 034, Telangana, India </font></p><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;line-height: normal"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;line-height: normal"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">CIN: L85195TG1984PLC004507</font></p><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;line-height: normal"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;line-height: normal"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Tel:&#160;&#160;&#160;&#160;&#160;&#160; + 91 40 4900 2900</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;line-height: normal"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Fax:&#160;&#160;&#160;&#160; + 91 40 4900 2999</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;line-height: normal"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Email: <u>mail@drreddys.com</u></font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;line-height: normal"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Web:&#160;&#160; <u>www.drreddys.com</u></font><font class="" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;"></font></p></td></tr></table><div class="emptyHTML" style="clear:both;max-height:0pt;;text-indent: 0px;"></div><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; color: rgb(0, 0, 0); white-space: pre-wrap; background: none; letter-spacing: 0px; top: 0px;">&#160;</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;">September 22, 2025</font></p><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; color: rgb(0, 0, 0); white-space: pre-wrap; background: none; letter-spacing: 0px; top: 0px;">&#160;</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;">National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;">BSE Limited (Scrip Code: 500124)</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;">New York Stock Exchange Inc. (Stock Code: RDY)</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;">NSE IFSC Ltd. (Stock Code: DRREDDY)</font></p><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; color: rgb(0, 0, 0); white-space: pre-wrap; background: none; letter-spacing: 0px; top: 0px;">&#160;</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;">Dear Sir/Madam,</font></p><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;background: none;text-indent: 0px"><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;">&#160;</font></b></p><table cellpadding="0" cellspacing="0" dtth="tableHanging" style="text-align:start; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-spacing: 0px; border-collapse: collapse; border-left-style: unset; border-right-style: unset; border-left-width: 0px; border-right-width: 0px;;text-indent: 0px;" width="100%"><tr style="vertical-align:top"><td style="width: 0in; overflow-wrap: break-word; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif;"></td><td style="width: 0.45in; vertical-align: top; overflow-wrap: break-word; font-family: &quot;Times New Roman&quot;, Times, serif;"><p class="convertHanging" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;margin-top: 0px;line-height: normal"><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;">Ref:</font></b></p></td><td style="text-align: justify; vertical-align: top; overflow-wrap: break-word; font-family: &quot;Times New Roman&quot;, Times, serif;"><p class="convertHanging" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;margin-top: 0px;line-height: normal"><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;"><u>Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015</u></font></b></p></td></tr></table><div class="emptyHTML" style="clear:both;max-height:0pt;;text-indent: 0px;"></div><p class="MsoNoSpacing nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 11pt;text-align: justify;font-family: &quot;Times New Roman&quot;, Times, serif;margin: 0px 0px 0px 0in;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Please find enclosed a Press Release <i>viz.</i> &#8220;Dr. Reddy&#8217;s receives positive CHMP opinion from European Medicines Agency for AVT03 (denosumab), a proposed Biosimilar of Prolia&#174; and Xgeva&#174;&#8221;</font></p><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; color: rgb(0, 0, 0); white-space: pre-wrap; background: none; letter-spacing: 0px; top: 0px;">&#160;</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;">This is for your information and records.</font></p><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; color: rgb(0, 0, 0); white-space: pre-wrap; background: none; letter-spacing: 0px; top: 0px;">&#160;</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;">Thanking you,</font></p><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; color: rgb(0, 0, 0); white-space: pre-wrap; background: none; letter-spacing: 0px; top: 0px;">&#160;</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;">Yours faithfully,</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;">For <b>Dr. Reddy&#8217;s Laboratories Limited</b></font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;background: none;text-indent: 0px"><img name="rdy0807_ex99-1img02.jpg" src="rdy0807_ex99-1img02.jpg" style="width: 133px; height: 56px;"><br></p><p class="Default" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 12pt;text-align: justify;font-family: &quot;Times New Roman&quot;, Times, serif;margin: 0px 0px 0px 0in;color: black;background: none;text-indent: 0px"><b><font style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">K Randhir Singh</font></b></p><p class="Default" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 12pt;text-align: justify;font-family: &quot;Times New Roman&quot;, Times, serif;margin: 0px 0px 0px 0in;color: black;background: none;text-indent: 0px"><i><font style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Company Secretary, Compliance Officer &amp; Head-CSR</font></i></p><p class="Default nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 12pt;text-align: justify;font-family: &quot;Times New Roman&quot;, Times, serif;margin: 0px 0px 0px 0in;color: black;background: none;text-indent: 0px"><font class="whitespaceprewrap" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><div style="border-bottom:1pt solid #000000; break-after:page;text-indent: 0px;" title="Page Break" class="cke_pagebreak"></div><p class="Default nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 12pt;text-align: justify;font-family: &quot;Times New Roman&quot;, Times, serif;margin: 0px 0px 0px 0in;color: black;background: none;text-indent: 0px"><font class="whitespaceprewrap" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p class="Default nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 12pt;font-family: &quot;Times New Roman&quot;, Times, serif;margin: 0px 0px 0px 0in;color: black;background: none;text-indent: 0px;text-align: center"><font class="whitespaceprewrap" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;"><img name="rdy0807_ex99-1img03.jpg" src="rdy0807_ex99-1img03.jpg" style="width: 875px; height: 84px;"></font><br></p><p align="center" class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: center;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;background: none;text-indent: 0px"><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></b></p><table cellpadding="0" cellspacing="0" class="Table" style="text-align:start; width: 100%; border-collapse: collapse; border-left-style: unset; border-right-style: unset; border-left-width: 0px; border-right-width: 0px; text-indent: 0px; border-spacing: 0px;" width="100%"><tr><td style="padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif;" valign="top" width=""><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;line-height: normal"><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></b></p></td><td colspan="2" style="padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif;" valign="top" width=""><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;line-height: normal;text-align: center"><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-transform: uppercase; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">CONTACT</font></b></p></td></tr><tr><td style="width: 50%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif;" valign="top" width="50%"><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 12pt;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;margin-right: 0px;line-height: normal"><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">DR. REDDY'S LABORATORIES LTD.</font></b><font class="" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;"></font></p></td><td style="width: 30%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif;" valign="top" width="30%"><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;line-height: normal"><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-transform: uppercase; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Investor relationS</font></b></p></td><td style="width: 20%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif;" valign="top" width="20%"><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;line-height: normal"><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-transform: uppercase; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Media relationS</font></b></p></td></tr><tr><td style="width: 50%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif;" valign="top" width="50%"><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;line-height: normal"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">8-2-337, Road No. 3, Banjara Hills, &#160;</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;line-height: normal"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Hyderabad - 500034. Telangana, India.<b> </b></font></p></td><td style="width: 30%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif;" valign="top" width="30%"><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 12pt;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;margin-right: 0px;line-height: normal"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-transform: uppercase; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">RICHA PERIWAL </font><br></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 12pt;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;margin-right: 0px;line-height: normal"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-transform: uppercase; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;"><u>richaperiwal@drreddys.com</u></font><font class="" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;"></font></p></td><td style="width: 20%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif;" valign="top" width="20%"><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;line-height: normal"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-transform: uppercase; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">priya K</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;line-height: normal"><u><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;"><font style="text-transform: uppercase; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">PRIYAK@drreddys.com</font></font></u><font class="" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;"></font></p></td></tr></table><div class="emptyHTML" style="clear:both;max-height:0pt;;text-indent: 0px;"></div><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p align="center" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: center;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;background: none;text-indent: 0px"><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Dr. Reddy&#8217;s receives positive CHMP opinion from European </font></b></p><p align="center" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: center;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;background: none;text-indent: 0px"><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Medicines Agency for AVT03 (denosumab), a Proposed Biosimilar of </font></b></p><p align="center" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: center;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;background: none;text-indent: 0px"><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Prolia<sup>&#174;</sup> and Xgeva<sup>&#174;</sup></font></b></p><p align="center" class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: center;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;background: none;text-indent: 0px"><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></b></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;margin-right: 0px;background: none;text-indent: 0px"><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Hyderabad India; September 22, 2025</font></b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#8211; Dr. Reddy&#8217;s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as &#8220;Dr. Reddy&#8217;s&#8221;), today announced that the European Medicines Agency&#8217;s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending marketing authorisation for AVT03, a biosimilar of Prolia<sup>&#174;</sup> (denosumab) and Xgeva<sup>&#174;</sup> (denosumab) in European markets.</font></p><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">As part of the established approval process, the CHMP positive opinion will now be reviewed by the European Commission (EC), following which a decision will be made on the grant of marketing authorisation in the European Economic Area (EEA), which includes the European Union (EU) member countries, in addition to Norway, Iceland and Liechtenstein. A Marketing Authorisation Application (MAA) for submission to the UK Medicines and Healthcare products Regulatory Agency (MHRA) will be made separately in keeping with the reliance route under the International Recognition Procedure (IRP).</font></p><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Prolia<sup>&#174;</sup> is a prescription medicine used to treat osteoporosis in women who have been through menopause and in men who are at increased risk of fractures, bone loss linked to hormone ablation in men with prostate cancer at increased risk of fractures and bone loss associated with long-term treatment with systemic glucocorticoid <sup>[1].</sup> Xgeva<sup>&#174; </sup>is a prescription medicine used to prevent bone complications in adults with advanced cancer involving bone and for the treatment of adults and skeletally mature adolescents with giant cell tumour of bone <sup>[2].</sup></font></p><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">In May 2024, Dr. Reddy&#8217;s and Alvotech entered into a license and supply agreement for the commercialization of AVT03. Under the agreement, Alvotech will develop and manufacture AVT03, while Dr. Reddy&#8217;s is responsible for registration and commercialization in applicable markets, including the U.S. and Europe. Dr. Reddy&#8217;s commercialization rights are exclusive for the U.S., and semi-exclusive for Europe and the UK. Upon approval Dr. Reddy&#8217;s will offer the biosimilar under the tradenames Acvybra<sup>&#174;</sup> (denosumab) 60 mg/mL solution for injection in a pre-filled syringe and Xbonzy<sup>&#174; </sup>(denosumab) 70 mg/mL solution for injection in a vial.</font></p><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><div style="border-bottom:1pt solid #000000; break-after:page;text-indent: 0px;" title="Page Break" class="cke_pagebreak"></div><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;background: none;text-indent: 0px"><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;"><font>&#160;</font><font>&#160;</font><font>&#160;</font><font>&#160;</font></font></b></p><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;background: none;text-indent: 0px"><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></b><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">About AVT03</font></b></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">AVT03 is a human monoclonal IgG2 antibody and biosimilar candidate to Prolia<sup>&#174;</sup> and Xgeva<sup>&#174;</sup>, which are both denosumab but in different presentations. Denosumab targets and binds with high affinity and specificity to the RANK ligand membrane protein, preventing the RANK ligand/RANK interaction from occurring, resulting in reduced osteoclast numbers and function, thereby decreasing bone resorption and cancer-induced bone destruction<sup>[1]</sup>. </font></p><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;background: none;text-indent: 0px"><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></b></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;background: none;text-indent: 0px"><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">References</font></b></p><table cellpadding="0" cellspacing="0" dtth="tableHanging" style="text-align:start; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-spacing: 0px; border-collapse: collapse; border-left-style: unset; border-right-style: unset; border-left-width: 0px; border-right-width: 0px;;text-indent: 0px;" width="100%"><tr style="vertical-align:top"><td style="width: 0in; overflow-wrap: break-word; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif;"></td><td style="width: 0.25in; vertical-align: top; overflow-wrap: break-word; font-family: &quot;Times New Roman&quot;, Times, serif;"><p class="convertHanging" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;margin-top: 0px;line-height: normal"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">1.</font></p></td><td style="vertical-align: top; overflow-wrap: break-word; font-family: &quot;Times New Roman&quot;, Times, serif;"><p class="convertHanging" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;margin-top: 0px;line-height: normal"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Amgen Inc. Prolia<sup>&#174; </sup>(Denosumab): Prescribing Information. Downloaded from: <u>https://www.pi.amgen.com/-/media/Project/Amgen/Repository/pi-amgen-com/Prolia/prolia_pi.pdf</u></font></p></td></tr></table><div class="emptyHTML" style="clear:both;max-height:0pt;;text-indent: 0px;"></div><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><table cellpadding="0" cellspacing="0" dtth="tableHanging" style="text-align:start; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-spacing: 0px; border-collapse: collapse; border-left-style: unset; border-right-style: unset; border-left-width: 0px; border-right-width: 0px;;text-indent: 0px;" width="100%"><tr style="vertical-align:top"><td style="width: 0in; overflow-wrap: break-word; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif;"></td><td style="width: 0.25in; vertical-align: top; overflow-wrap: break-word; font-family: &quot;Times New Roman&quot;, Times, serif;"><p class="convertHanging" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;margin-top: 0px;line-height: normal"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">2.</font></p></td><td style="vertical-align: top; overflow-wrap: break-word; font-family: &quot;Times New Roman&quot;, Times, serif;"><p class="convertHanging" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;margin-top: 0px;line-height: normal"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Amgen Inc. Xgeva<sup>&#174;</sup> (Denosumab): Prescribing Information. Downloaded from: <u>https://www.pi.amgen.com/-/media/Project/Amgen/Repository/pi-amgen-com/xgeva/xgeva_pi.pdf </u></font></p></td></tr></table><div class="emptyHTML" style="clear:both;max-height:0pt;;text-indent: 0px;"></div><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;font-size: 12pt;margin: 0px 0px 0px 0in;font-family: &quot;Times New Roman&quot;, Times, serif;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;background: none;text-indent: 0px"><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Use of trademarks</font></b></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Prolia<sup>&#174;</sup> and Xgeva<sup>&#174;</sup> are registered trademarks of Amgen Inc.</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;background: none;text-indent: 0px"><font class="" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;"></font><br></p><div class="nonEmpty" style="border-bottom:solid windowtext 1.0pt; padding:0in 0in 1.0pt 0in;text-indent: 0px;"><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;border: none;text-align: justify;padding: 0in;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;margin-right: 0px;margin-bottom: 0px;background: none"></p></div><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;background: none;text-indent: 0px"><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></b></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;margin-right: 0px;background: none;text-indent: 0px"><b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">About Dr. Reddy&#8217;s</font></b><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">: Dr. Reddy&#8217;s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed to providing access to affordable and innovative medicines. Driven by our purpose of &#8216;Good Health Can&#8217;t Wait&#8217;, we offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Our major markets include &#8211; USA, India, Russia &amp; CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in businesses of the future. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. </font></p><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Over the last 25 years, our Biologics team has developed into a fully integrated organization with robust capabilities in the development, manufacture and commercialization of a range of biosimilar products in oncology and immunology. We have a current portfolio of six commercial products marketed in India, with some products marketed in more than 30 other countries. In addition, we have several products in the pipeline in oncology and auto-immune diseases in various stages of development for global launches across&#160; developed as well as emerging markets. We are also ramping up manufacturing capacity to support our global expansion plans. In 2024, we launched our first biosimilar in the United Kingdom, Versavo&#174; (biosimilar bevacizumab). This follows our launch of pegfilgrastim in the U.S and Europe through our partner. Our biosimilars business has a key role to play in driving both near-term and long-term growth.</font></p><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;margin-right: 0px;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">For more information, log on to: </font><u><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">www.drreddys.com</font><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">.</font></u></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;margin-right: 0px;background: none;text-indent: 0px"><font class="" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;"></font><br></p><div class="nonEmpty" style="border-bottom:solid windowtext 1.0pt; padding:0in 0in 1.0pt 0in;text-indent: 0px;"><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;border: none;text-align: justify;padding: 0in;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;margin-right: 0px;margin-bottom: 0px;background: none"></p></div><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><p style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;margin-bottom: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;margin-right: 0px;background: none;text-indent: 0px"><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">Disclaimer: This press release may include statements of future expectations and other forward-looking statements that are based on the management&#8217;s current views and assumptions and involve known or unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. In addition to statements which are forward-looking by reason of context, the words "may", "will", "should", "expects", "plans", "intends", "anticipates", "believes", "estimates", "predicts", "potential", or "continue" and similar expressions identify forward-looking statements. Actual results, performance or events may differ materially from those in such statements due to without limitation, (i) general economic conditions such as performance of financial markets, credit defaults , currency exchange rates, interest rates, persistency levels and frequency / severity of insured loss events, (ii) mortality and morbidity levels and trends, (iii) changing levels of competition and general competitive factors, (iv) changes in laws and regulations and in the policies of central banks and/or governments, (v) the impact of acquisitions or reorganization, including related integration issues</font><font lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">, and (vi) the susceptibility of our industry and the markets addressed by our, and our customers&#8217;, products and services to economic downturns as a result of natural disasters, epidemics, pandemics or other widespread illness, including coronavirus (or COVID-19), and (vii) other risks and uncertainties identified in our public filings with the Securities and Exchange Commission, including those listed under the "Risk Factors" and "Forward-Looking Statements" sections of our Annual Report on Form 20-F for the year ended March 31, 2025. The company assumes no obligation to update any information contained herein.</font><font class="" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;"></font></p><p class="nonEmpty nonEmpty" style="-webkit-margin-before: 0em;-webkit-margin-after: 0em;text-align: justify;margin-top: 0px;font-family: &quot;Times New Roman&quot;, Times, serif;font-size: 10pt;margin-right: 0px;margin-bottom: 0px;background: none;text-indent: 0px"><font class="whitespaceprewrap" lang="EN-US" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;">&#160;</font></p><div style="border-bottom:1pt solid #000000; break-after:page;text-indent: 0px;" title="Page Break" class="cke_pagebreak"></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>rdy0807_ex99-1img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 rdy0807_ex99-1img01.jpg
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M>'!A8VME="!E;F0](G(B/S[_[0!(4&AO=&]S:&]P(#,N,  X0DE-! 0
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M\L:J ??[M3W JB8Y2O7<23]X--)/ZV;T\Z]9[W!F[$!$!!LN("'T"402.(&
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M(^DC5%,RIC%*01ZW%Y%E\;Q[C][G,Q*L&(@M9'DD8@+M"$[03XN>H50"6)
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M?:KE?U&\8P^[MI;YVYXV[. (K":\M0]1O,=898U>H^+81XFHJ=*+*YRT"?\
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MM-JL+<7\$T"^(W^DLD<:D^&XJ"?"ITCOGR+D&_\ 5KY;@1^@$ :84'^W_?\
-Z^JNZ^>F_77HT:__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>rdy0807_ex99-1img02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 rdy0807_ex99-1img02.jpg
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M P,# P,#_\  $0@ . "% P$1  (1 0,1 ?_$ )H   (" @,!
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MF)AF[AIE&:'"^YS]B-JN'NZ"B6[UOOKG.V=M=@)3NOD;D5_E?@?CO@*]BY$
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M.G?<ETZN(9:9(F/'#WF0ECAQE<JD7GWNHQ)]*KAZ@FC+>>FTFV>J,=?Z'F?
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M::F;_@2V_P"8%YZQ(-O04;<57INK47GP.3:(,P0@FM7C,UUCF;Z5;*;O/<M
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M];5TQ/:N]-M5=9+'U<9QGP =!%.576XE/ @* C P'%)">%I,.1D6W3BR$FM
M@ERJQ)R;;[ZJ8E)(R(9YX[D%5_7LY5<;^KSQGR\ "=8<Q<^TM*#\U5-1A0'+
MBE0"M #<D/1";-["TH#S4R1!]8Q[C&VZB <-S9"]<LV>,_304<[YUQC&?+P
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&WVTR!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>rdy0807_ex99-1img03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 rdy0807_ex99-1img03.jpg
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M P,# P,#_\  $0@ 5 -K P$1  (1 0,1 ?_$ -<  0 !! (# 0
M   )! 8("@4' 0(#"P$!   ' 0$               $#! 4&!P@""1    8!
M @() @,""P(+" ,  0(#! 4&  <($0D2$R-CH]065I8A%#$5"E$B<3*T-45U
MM39VAL9!D6&!0E(S4R2V-W<9T4-4)54F%Q@Y&CH1  $# @(%"@,$!@<%!@<
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M?R.9\[CTS+?+P>&SJ3 S8.95YKM=/RI$?6%KX_FCH./J.8X\ 9,A ./WO'@
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M'X@0Y3#_ +BB(X+7#6"$7TSRH)A$PB81>YTU$Q %"'3$0Z0 <IB")1_ P 8
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MII,WFCQLMK=@DF[NI >_$YC(V$@AI>\%U#A:0"5ZO<SM; ALQ)D(KA&DTV[
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M.5IJ[?56SQCUVNGU[H&Z"K,4#IKE4(<I=Y>YK@-O_O3OJWB)N3;F_AF@A;)
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M :+Q^IP<H0FV3;!;BL(UY*57='$2D>>21*HCT6E$M\HNP<'$!.$;(JQ2)7)
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M[+GY%9OQ,)D[QS3AP&3!#;QNEDPZ*RR G35PJ2:67*\YO V*\E9W33MKR5T
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= /O_ .[_ '?OO_VY2]KZCX?O>7_@*'Q^W]"__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
